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Abstract
Densely arrayed skeletal myotubes are activated individually and as a group using precise optical
stimulation with high spatiotemporal resolution. Skeletal muscle myoblasts are genetically
encoded to express light-activated cation channel, Channelrhodopsin-2, which allows for
spatiotemporal coordination of the multitude of skeletal myotubes that contract in response to
pulsed blue light. Furthermore, ensembles of mature functional 3D muscle microtissues have been
formed from the optogenetically encoded myoblasts using a high-throughput device. The device,
called “skeletal muscle on a chip”, not only provides the myoblasts with controlled stress and
constraints necessary for muscle alignment, fusion and maturation, but also facilitates to measure
forces and characterize the muscle tissue. We measured the specific static and dynamic stresses
generated by the microtissues, and characterized the morphology and alignment of the myotubes
within the constructs. The device allows for testing the effect of a wide range of parameters (cell
source, matrix composition, microtissue geometry, auxotonic load, growth factors, and exercise)
on the maturation, structure, and function of the engineered muscle tissues in a combinatorial
manner. Our studies integrate tools from optogenetics and microelectromechanical systems
(MEMS) technology with skeletal muscle tissue engineering to open up opportunities to generate
soft robots actuated by multitude of spatiotemporally coordinated 3D skeletal muscle microtissues.
Introduction
Locomotion is a key feature to animal survival and it involves the coordination of a large
number of muscles in space and time. Animals perform a variety of complex movements
such as flying and swimming by oscillating their wings or undulating their bodies with high
spatiotemporal coordination. They adapt their locomotive gaits to their physical
surroundings and navigate different environments by continuously changing the patterns of
muscle activity (1). Muscle is an efficient actuator having superior power-to-weight ratio,
force-to-weight ratio, compliance, plasticity, scalability and controllability when compared
with traditional robotic actuators (2). Engineered muscle tissues in vitro have the potential to
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replicate some of these performance characteristics of their in vivo counterparts and serve as
powering units for soft robotic devices demonstrating life-like mobility (3–5).
Previous work addressed the integration of engineered muscles with synthetic structures to
develop functional biological machines (4–10). These biohybrid constructs display
biomimetric functionality (5–7), and can even mimic the propulsion mechanism of jellyfish
(4). The basic design principle of these devices is to form a self-assembled 2D cardiac
muscle tissue on elastic surfaces. The synchronous contraction of muscle cells causes the
substrate to bend and take 3D conformations. Skeletal muscle has several features making it
more favorable than cardiac muscle for the production and regulation of force for
locomotion (11). The organization of skeletal muscle is modular, having many
longitudinally aligned, multinucleated muscle fibers assembled together by connective tissue
to form a densely packed structure (12). By adjusting the number of muscle fibers
contracting within a muscle and the tension developed by each contracting fiber, the nervous
system effectively achieves controlled, graded tension. To achieve this selectivity,
motoneurons innervate skeletal muscle cells at very localized regions called neuromuscular
junctions (13). The variability in the arrangement of connections among multiple muscle
units combined with precise spatiotemporal activation of individual units generates a wide
range of motions (14).
The real potential of engineered skeletal muscle as a multi-degree of freedom, scalable, and
robust actuator can be revealed with the formation of 3D anisotropic tissue-level
organization and the application of neuron-like targeted stimulation protocols. Electrical
stimulation techniques offer activation of excitable cells with precise timing but the spatial
resolution of extracellular electrode arrays is limited. Intracellular electrodes can target
specific muscle cells (15) but the electrodes should be either directly attached or placed in
close proximity to the muscle fibers, which limits the type of activation patterns and the
mechanical design of the mobile constructs. Optogenetics enable fast, precise, and localized
stimulation of genetically engineered excitable cells in vitro and in vivo (16, 17). The
minimally invasive and targeted nature of photostimulation makes it possible to control
muscle activity in real-time even in freely behaving animals (17–22).
The current work aims to accomplish photostimulation of 3D skeletal muscle microtissues
for spatiotemporally precise coordination of multiple muscle units. Functional hydrogel-
based skeletal muscle tissues with dense, aligned and highly differentiated muscle fibers
have been engineered in several different bioreactors for various different applications (23–
33). Recent work addressed methods to control the final 3D tissue architecture using
microfabrication technology (33–35), but still little quantitative data are available on the
mechanical and chemical factors affecting the structure and function of individual cells
inside the tissue. Understanding myogenesis, examining the mechanical interplay between
muscle cells and the surrounding extracellular matrix during development, and performing
combinatorial perturbation experiments (applying different mechanical and soluble stimuli
and excitation protocols) are important requirements for optimizing the performance of
engineered actuators especially for microscale applications. A high-throughput, miniaturized
platform that allows monitoring of cell-matrix interactions as well as changes in myofiber
morphology and rapid recording of microtissue force generation can characterize these
properties. This platform can also serve as a skeletal muscle on a chip analogous to heart on
a chip for tissue-level pharmacological studies (36, 37).
In our previous work, we introduced microfabricated tissue gauges (μTUGs), which
simultaneously constrain and report forces generated by the microtissues in real-time (38,
39). Here, we integrate optical tools and transgenic expression of light-gated ion channels
with this multi-purpose device to engineer light-activated, 3D skeletal muscle microtissues
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and demonstrate multi-DOF motion. We first show that genetically engineered C2C12
murine muscle myoblasts expressing Channelrhodopsin-2 (ChR2) fuse to form functional
myotubes on 2D surfaces and individual cells can be selectively activated with confined
illumination. Once incorporated into our device, these myoblasts self-assemble and generate
hundreds of 3D microtissues with longitudinally aligned and differentiated myofibers. The
microtissues are activated upon exposure to brief light pulses, and we characterize the
contractility of the tissue by monitoring the deformations of elastic microposts. With local
stimulation, we demonstrate different modes of contraction patterns.
Results and Discussion
Development and optical stimulation of ChR2-expressing C2C12 myotubes
Skeletal muscle formation involves multiple distinct steps. Precursor cells called myoblasts
proliferate, locally align and begin to fuse to form multinucleated myotubes. Myotubes grow
in length and get thicker as more myoblasts merge with the developing fiber and the interior
is filled with contractile proteins to form functional muscle fibers. Previous work showed
that ChR2 enables temporally precise (tens of milliseconds) and spatially confined control of
cardiac muscle contraction (17). A recent work reported the feasibility of optical control for
skeletal muscle contractions (40). Here, we extend the results of this work by demonstrating
selective activation of individual myotubes with confined illumination as well as formation,
characterization and optical control of genetically engineered, 3D skeletal muscle
microtissues. We generated a stable mouse skeletal muscle cell line (C2C12-ChR2)
expressing ChR2-green fluorescent protein (GFP) fusion protein from the chicken β-actin
promoter (CAG) using a non-viral strategy. Transfected myoblasts showed membrane-
bound GFP signal (Fig. 1A), and they fused with each other to form ChR2-positive
myotubes (Fig. 1B). Staining for muscle-specific protein α-actinin after 3 weeks in
differentiation medium revealed striations indicative of sarcomeric structure and a sign of
maturation (Fig. S2).
At day 10 of differentiation, application of pulsed blue light depolarized the cell membrane
(Fig. S3) and induced cellular contractions in ChR2-positive myotubes, and did not induce
contractions in non-transfected control myotubes. There is a non-linear, inverse relationship
between the energy and the duration of light pulses required for the induction of muscle
contractions (41). We observed repeatable and reliable myotube contractions with 20 ms
pulses at 10 mW/mm2 light intensity. Figure 1C shows a representative twitch profile
induced by a single light pulse. The cells started to contract almost instantaneously, 17.3 ±
2.5 ms after light was turned on. Both ends of the myotubes were fixed onto the surface so
we could not measure generated force. Instead, we tracked single points on the cell body to
quantify the contractions, and normalized each point’s displacement measurement with the
maximum displacement of the point. The total duration of twitch (contraction and
relaxation) showed great variability, ranging from 300 ms to more than a second as
myotubes cultured on 2D surfaces have different levels of maturation.
Selective activation of C2C12-expressing myotubes using focused illumination
Next we investigated whether local stimulation induces contractions in functional myotubes.
We generated light pulses with a diameter of 20 μm to selectively activate individual cells.
For the tested fibers (n = 30 myotubes), pulsed illumination of one confined region (less
than 10% of the total area of the cell) evoked contractile activity within the entire myotube
body. The resulting twitch profile of local illumination closely resembles the profile
generated by exposing the whole myotube with pulsed light at the same intensity (Fig. 1D).
Based on this result, we generated a proof-of-concept experiment to demonstrate selective
activation of myotubes using confined illumination (Fig. 1E and Movie S1). We selected 3
Sakar et al. Page 3
Lab Chip. Author manuscript; available in PMC 2013 December 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
myotubes (M1, M2, and M3) located in close proximity. By changing the region of exposure
(R1, R2, and R3), we activated single myotubes individually or multiple myotubes
collectively (Fig. 1F). Thus, ChR2 can be used for precise local stimulation of myotubes in
vitro.
Formation of 3D Muscle Tissues from ChR2-expressing myoblasts
Formation of functional skeletal muscle actuators requires structural organization at multiple
length scales. The molecular level intracellular organization of myofibers is important for
generating force effectively. The tissue level alignment of densely packed fibers inside the
3D muscle construct is critical for maximal transmission of the force throughout the muscle.
To generate optically activated skeletal muscle microtissues demonstrating the basic
contractile functionality, we fabricated T-shaped cantilevers incorporated inside arrays of
micro-patterned wells within a PDMS mold (Fig. S4). The wells are filled with a suspension
of genetically engineered myoblasts and liquid neutralized collagen I supplemented with
Matrigel using a centrifugation-aspiration protocol (Fig. 2A). We chose collagen because it
has been shown that naturally derived hydrogels undergo macroscale compaction when
mixed with skeletal muscle myoblasts, which leads to high cell density and unidirectional
cell alignment in the presence of engineered geometric constraints (32). The round
myoblasts elongate, spread inside the polymerized gel and apply traction forces that
spontaneously compact the matrix over time. Cells are distributed throughout the tissue, and
the collective action of these local processes results in bulk contraction of the collagen gel.
Elastic cantilevers restrict hydrogel compaction, and act as artificial tendons to anchor the
skeletal muscle microtissues (SMTs) around the caps of the posts (Fig. 2B). Wide caps at the
tips of the cantilevers ensure that microtissues do not slide off the top of the posts and
remain anchored throughout the experiments. Using this reproducible fabrication technique,
we generated a 10 × 13 array of 3D, free-standing constructs.
Remodeling and compaction of the matrix during the first 2 days of development in growth
medium resulted in a marked reduction of construct size (final width 144.2 ± 6.4 μm at the
thinnest portion of the construct) and a nearly 10-fold increase in the cell density. The
densely packed cells were evenly distributed throughout the tissue and uniform GFP
expression identified expression of ChR2 by almost all of the cells (Fig. 2C). The presence
of cantilevers generates anisotropic boundary conditions inside the tissue, and the imposed
stress on the matrix led to cell alignment (Fig. 2D). We previously showed that cytoskeletal
tension corresponds to simulated stress gradients and actin filaments align in the direction of
predicted principal stresses (38). Cells stretched out along stress gradients showed actin
alignment and elongated nuclei morphology, which eventually led to patterned
differentiation of myotubes during self-assembly by myoblasts. After switching to
differentiation medium, aligned myoblasts start to fuse with each other, and extensive
cytoskeletal reorganization occurs during this period. Visualization of F-actin protein inside
the myotubes reveals the formation of arrays of parallel filaments along the cell body (Fig.
2E).
We fabricated cantilevers with different spring constants (k = 0.2–0.45 mN/mm) by varying
the ratio between PDMS and curing agent (Fig 2F). Microtissues formed around relatively
rigid posts exhibited significant thinning and high rates of rupture in the second week of
culture. This is the time period when myotubes start to mature and contract spontaneously.
As the stiffness of the cantilevers is decreased, the amount of deflection reaches a point
where cantilevers start to show nonlinear responses, which causes a difficulty in force
calibration. For this reason, we used cantilevers with an intermediate spring constant of 0.33
mN/mm for all the remaining experiments. By changing the dimensions of the cantilevers
and the wells, we can control the final geometry of constructs. Wider posts result in thicker
microtissues while increasing the interpost distance generates longer microtissues (Fig 2F).
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Cell morphology, alignment and differentiation in SMTs
After 3 weeks in culture, staining for α-actinin showed multiple longitudinally aligned
myotubes within each microtissue (Fig. 3). Even though microtissues had similar
dimensions and number of myoblasts at the time of switching to differentiation medium,
they ended up having different numbers of myotubes (Fig. 3A–C). The final size of the
constructs allowed at most 3 myotubes to form on top of each other (Fig. 3B). They had 7
myotubes on average (data from 20 SMTs) and most of the myotubes had well-developed
parallel cross-striations, consistent with sarcomeric structure (Fig. 3D). Average fiber
diameter was 19.24 ± 2.62 μm (n = 140 myotubes from 20 SMTs), and they were as thick as
39 μm. The micrometer scale of the SMTs allows visualization of the fine-scale sarcomeric
structure of the cells (Fig 3E) and reconstruction of the 3D muscle architecture of the whole
microtissue (Fig. 3F) using confocal microscopy. Centimeter-scale constructs require
histological sectioning to visualize the interior of the tissue, which is a significant obstacle
for high-throughput analysis. Muscle fibers are present even at the core of the microtissues
and on average occupy 13 ± 2.6 percent of the construct. C2C12 myotubes show well-
developed striations when they are cultured on substrates with tissue-like stiffness (E
approximately 12 kPa) after 2–4 weeks of differentiation (42). In a recent work, Chiron et al.
cultured human myoblasts in a fibrin gel between centimeter scale elastic posts and reported
the change in tissue stiffness using AFM (43). They observed that engineered skeletal
muscle tissue stiffness increases upon differentiation, with E reaching 12.2 kPa. The
presence of well-developed cross-striations could be explained with this change in matrix
stiffness as we used a miniaturized version of the same system. Furthermore, the auxotonic
load due to elastic boundary conditions (i.e. PDMS cantilevers, mimicking attachment of
muscle to elastic tendons) can accelerate the muscle maturation (39).
The degree of alignment was quantified using 2D projection of images of microtissues
stained for alpha-actinin. The angle was defined as the angle between the major axis of each
myotube and the longitudinal axis of the construct (Fig. 3G). In the generated constructs, an
orientation angle of 0° indicates perfect alignment and ± 45° represents random alignment.
The average length between the caps of the microposts (l1) was 350 μm and the average
length of the microtissue (l2) was 510 μm. When the myotube formed diagonally between
the posts the orientation angle was around ± 30° (denoted by dashed blue lines in Fig. 3G),
and the myotubes were as long as 550 μm if they formed on top of the caps. Figure 3H
shows a scatter plot of the orientation and length of 140 myotubes from 20 different
constructs. Most of the myotubes spanned almost the entire length between the microposts
(79.2%). We observed occasional myotube formation that is parallel and close to the caps of
the posts where the stress was not aligned with the major axis of the tissue. Data points with
an orientation angle close to ± 90° represent these myotubes (Fig. 3G).
Optical stimulation of SMTs
During tissue formation, a baseline static tension is developed due to the compaction of the
gel by the collective action of myoblasts. Myotubes form in the presence of this static stress,
they become mature, and generate forces when stimulated. The dynamic tension is defined
as the force exerted during light-activated contractions of myotubes. The amount of tension
generated is calculated by measuring the cantilever deflection (Fig. 4A). At day 14 of
differentiation, application of pulsed blue light reliably induced contractions of SMTs
(Movie S2). The active force generated by these contractions was 1.41 ± 0.25 μN while the
static tension between cantilevers was 10.8 ± 0.18 μN (Fig. 4B). These values are
comparable with our previous results on spontaneously contracting cardiac microtissues
generated by the same device (39). In accordance with 2D stimulation experiments, the
microtissues started to contract 20.6 ± 3.2 ms after light was turned on. However, unlike 2D
experiments, the duration of contraction and relaxation were consistent among SMTs, 190.9
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± 11.5 ms and 279.4 ± 16.8 ms, respectively. This consistency is probably due to a more
uniform maturation of myotubes within microtissues. These values are relatively long
compared to the contraction durations measured in centimeter-scale skeletal muscle tissues
(31, 32). This difference could be due to the stimulation protocol, properties of ECM
(collagen I vs. fibrin), or the cell source (neonatal rat skeletal myoblasts vs. immortalized
mouse cell line). Microtissues exposed to blue light for extended time periods become
irresponsive to light stimulation for several seconds. Previous work addressed this refractory
period in muscle cells and suggests that ChR2-induced sustained depolarization leads to
inactivation of Na+ channels (18).
Specific tension or cross-sectional stress (i.e., tension normalized over cross-sectional area)
is commonly used to compare the engineered muscle tissue with native muscle. The average
cross sectional area of the SMTs was 0. 0125 mm2 (n = 50 SMTs). The average passive
cross-sectional stress was 0.864 kPa and the average active cross-sectional stress was 0.112
kPa. To obtain a better understanding of the force production potential of microtissues, we
calculated the effective dynamic cross-sectional tension. The average effective cross-
sectional area is the area occupied by the myotubes and this value was 0.0012 mm2 as
almost 90% of the cross-sectional area was filled by non-contractile myoblasts and collagen
gel. As a result, the effective dynamic cross-sectional tension was 1.12 kPa, which is
comparable to previous reports on engineered muscle tissue (31) but much lower than the
native adult skeletal muscle performance (260 kPa).
Multi-DOF actuation using confined illumination
With optical stimulation, SMTs can be activated simultaneously as well as separately. One
of our objectives in this study was to demonstrate multi-DOF actuation within a single
engineered muscle actuator. We have already shown that myotubes grown on a surface can
be activated selectively. To demonstrate multi-axes motion, we illuminated different regions
of a single microtissue with blue light pulses (Movie S3). When fully stimulated, the
microtissue contracted uniformly resulting in a bending of the posts as measured by the
translation of the caps (Fig. 4C). All of the functional myotubes within the tissue were
activated and they collectively generated 2.1 μN of dynamic tension. Alternatively, when a
one side of the SMT was stimulated, only the myotubes located on that side were activated.
As a result, the microtissue exhibited a torsional movement as measured by the rotation and
translation of the caps (Fig. 4D, E). The dominant mode of motion in selective activation
was rotation and the force generated by the contracting myotubes was measured as 0.85 μN
and 0.68 μN, respectively. In the presence of diagonal myotubes (Fig. 3D), stimulation of
the whole tissue resulted in both bending and torsion of the posts (Movie S2).
The optimization of actuator performance
We employed C2C12 skeletal muscle cells as they come from a well-established cell line
(44), but our approach to generate optically controllable microtissues can be applied using
other muscle cell types. Recent work shows that embryonic myoblasts isolated from
invertebrates have the potential to perform mechanical work (45). As these cells can
function at ambient conditions, they may be better suited for building robust bioactuators.
Our constructs are densely packed with viable myoblasts, but only sub-population (less than
40% of the myoblasts) fuses to form functional myotubes (Fig. 3F). This non-contractile
material does not produce work and adds stiffness, which impedes the optimal force output.
Previous work showed that this value could be as high as 80% in engineered tissue networks
(33). The superior myoblast fusion reported in (33) could be explained by the geometry of
the constructs, matrix composition, or the use of primary skeletal myoblasts. Treatment of
C2C12 cells with recombinant IGF-1 results in hypertrophy of differentiated myotubes on
2D surfaces (46), and the same treatment increases force generation in engineered skeletal
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muscle tissues (24). In our future work, we will explore the effect of all these factors on
myoblast fusion and myogenesis.
The composition of extracellular matrix (32, 47, 48) and the boundary stiffness (49) play an
important role in the development and contractile force generation of an engineered muscle
tissue. During development, the matrix composition affects the ability of the cells to
reorganize within the tissue and the internal structure of self-assembled myotubes. The
activity of the cells remodels the surrounding matrix (50). In turn, compaction of the matrix
by the cells bends the elastic posts, creating a mechanical preload on each construct. This
dynamic interplay among the cells, ECM and the elastic microposts determines the overall
functionality of the construct. After development, the passive viscoelastic properties of the
tissue determine the efficiency to store, transmit and release produced energy. In our
previous study, we generated cardiac microtissues using a similar system and showed that
the constructs with a denser collagen matrix (1 mg/mL vs 2.5 mg/mL) generate lower
dynamic cross-sectional stress. By increasing the post stiffness, we improved the cardiac
tissue development (39). Similarly, fine-tuning the matrix composition, the post stiffness
and the microtissue geometry may result in an increased alignment of the myotubes and a
better development of sarcomeric structure.
Skeletal muscle is one of the most adaptable (plastic) tissues in the body, and its structure
and physiology change with increased or decreased use (12). Repeated electrical stimulation
and cyclic stretch protocols are generally performed to exercise the engineered muscle
tissues (12, 23). However, there are conflicting results in the literature and optimal
stimulation parameters should be determined (51). Optical stimulation offers greater
flexibility for excitation under physiological conditions. Unlike electric fields, increasing
magnitude and duration of light pulses do not lead to electrochemical damage to muscle
tissue (18). High-power, micro-LED arrays (52) can easily be integrated with our high-
throughput device to examine the excitability and contractibility of hundreds of microtissues
in real-time under various different stimulation protocols. Cyclic stretch could be applied by
forming the microtissues between magnetic elastomeric cantilevers. In our previous work,
we showed the feasibility of this technique by applying external forces to living cells using
arrays of magnetic PDMS microposts (53).
Materials and Methods
Plasmid Contructs
pAAV-Cag-Chr2-GFP (a gift from Ed Boyden) was digested using enzymes BsrGI and
EcoRI (New England Biolabs, MA). 2A-Puro was amplified with forward primer
(GGACGAGCTGTACAAGGAGGGCCGCGGCAGCCTGCTGACC) and reverse primer
(ATTATCGATGAATTCTCAGGCACCGGGCTTGCGGGTCATGC) that added BsrGI
and EcoRI sites on the ends. The amplified PCR product was subsequently digested with
BsrGI and EcoRI and ligated with the digested pAAV-Cag-Chr2-GFP to form pAAV-Cag-
Chr2-GFP-2A-Puro (Fig. S1). Cloning was verified by DNA sequencing.
Cell culture and transfection
The murine-derived muscle cell line (C2C12) was purchased from American Type Culture
Collection (ATCC, Manassas, VA). For the generation of transgenic cell line, C2C12-ChR2,
cells were transfected with pAAV-Cag-Chr2-GFP-2A-Puro with Lipofectamine 2000
(Invitrogen, Carlsbad, CA), and were grown under Puromycin (2.5ug/ml) selection for 2
weeks. More than 98 percent of the population expresses ChR2 after selection.
For 2D stimulation experiments, C2C12-ChR2 cells were cultured in growth medium
containing high-glucose DMEM (ATCC, Manassas, VA), supplemented with 10% fetal
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bovine serum (FBS, Sigma, St. Louis, MO), and 1% penicillin-streptomycin (Invitrogen).
When cells reach 80–90% confluency, growth medium was switched to differentiation
medium containing high-glucose DMEM supplemented with 10% horse serum (Sigma, St.
Louis, MO) to facilitate myotube formation and the medium is replaced every day until the
termination of the experiment.
Device fabrication and microtissue seeding
We previously developed techniques to fabricate the SU-8 masters on silicon wafers (38).
Multiple layers of SU-8 photoresist (Microchem) were spin-coated on a master silicon wafer
to a final thickness of 250 μm. Elastomeric microtissue molds replicating the photoresist
features of the patterned master wafer were created using a double-casting method. A
negative replica PDMS template was first molded off the master wafer and then silanized to
make it nonadhesive to further application of PDMS. The silanized template was then used
to cast the final substrate that can be directly utilized as microtissue molds. The dimensions
and location of the PDMS cantilevers within the wells were varied by the use of different
photomasks to fabricate the corresponding masters. For force characterization experiments,
we embedded fluorescent microbeads (Fluoresbrite 17147; Polysciences, Inc.) into the
cantilevers to facilitate automatic tracking of cantilever deflection (39). Briefly, fluorescent
bead solution (in ethanol, 3000:1) was added onto PDMS stamps inside a six-well plate and
then centrifuged for 1 min at 1,000 rpm to settle the fluorescent beads into the pattern on the
stamps. The ethanol was then allowed to evaporate overnight at room temperature. PDMS
molds were then cast onto the stamps to produce the final uTUG substrates incorporated
with fluorescent beads.
The PDMS molds were sterilized in 70% ethanol followed by UV irradiation for 15 min and
treated with 0.2% (w/v) Pluronic F-127 (Invitogen) to reduce cell adhesion. A mixture of 2
mg/mL liquid neutralized collagen I from rat tail (BD Biosciences, Franklin Lakes, NJ)
supplemented with 10% (v/v) Matrigel (BD Biosciences, Franklin Lakes, NJ) was then
added to the surface of the substrates on ice and templates were degassed under vacuum to
remove bubbles in the liquid. Matrigel was added to support faster cell spreading. A cooled
suspension of cell-laden gel was then added to the substrate and the entire assembly was
centrifuged to drive the cells into the micropatterned wells, resulting in approximately 400
cells per well. Excess collagen and cells were removed by dewetting the surface of the
substrate before incubating at 37 °C to induce collagen polymerization. Growth medium
supplemented with 50 μg/mL L-ascorbic acid (Sigma, St. Louis, MO) and 33 μg/mL
aprotinin (Sigma, St. Louis, MO) were added to each device. After 4 days, growth medium
was switched to the differentiation medium supplemented with 50 μg/mL L-ascorbic acid
and 33 μg/mL aprotinin to induce myotube formation.
Optical stimulation in vitro
Light stimulation of single myotubes and microtissues was performed through a 20X
objective with a high-power LED unit (1.5W of collimated blue light, Prizmatix) or a 300-W
mercury lamp coupled with a GFP filter set (excitation wavelength 473 nm). Stimulation
triggers were generated by a function generator (Agilent) or synthesized by custom software
written in Metamorph and then exported to the shutter control unit. Power density of the
blue light was measured with a power meter (Thorlabs).
Quantification of microtissue force and cellular displacement
Images were acquired using an inverted microscope (Olympus IX2). The contractions of
myotubes (15 independent experiments) were recorded at 1 kHz using a high-speed camera
(Fastcam SA2, Photron USA, Inc.) at 20X magnification. The contractile displacement was
measured by tracking bright spots on the myotubes (at least 2 different points for each
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myotube) using ImageJ (National Institutes of Health). For quantifying static tension,
microtissues were cultured for 48 h before phase-contrast images were taken of the
cantilevers within each template (45 total, 15 each from 3 independent experiments), using a
CCD camera (Orca-R2, Hamamatsu Photonics K.K., Japan). To measure dynamic forces,
phase-contrast and fluorescence images were taken at 250 Hz (45 total, 15 each from 3
independent experiments), using a high-speed camera (Fastcam SA2, Photron USA, Inc.).
Only tissues that were uniformly anchored to the tips of the cantilevers were included in the
analysis. The displacement of the caps of the cantilevers was then tracked using ImageJ.
We calculated the spring constants of cantilevers using linear bending theory and calibrated
the spring constants based on experimental measurements with a MEMS capacitive force
sensor (FT-G30; Femto Tools) mounted on a micromanipulator (39). For each measurement,
the sensor tip was placed 20 μm below the cap of the post, and the probe was translated
laterally against the outer edge of the cantilever. Five cantilevers were measured across a
substrate and measurements were repeated for three different substrates under each
condition. These spring constants were then used to project the measured cantilever
deflections to the amount of force generated by SMTs.
Immunofluorescence Staining and image analysis
Constructs and cells were fixed with 4% paraformaldehyde and permeabilized with 0.2%
Triton X-100 (Sigma, St. Louis, MO). To visualize F-actin, cells and microtissues were
directly stained with Rhodamine Phalloidin (1:100, Invitrogen) and Hoechst nuclear dye
(1:1000, Invitrogen). To visualize the sarcomeric structure, microtissues were first blocked
with 3% goat serum in 5% bovine serum albumin (BSA, Sigma) and incubated with primary
antibodies (sarcomeric α-actinin, Sigma) overnight at 4°C. Secondary antibodies (Alexa
555, Sigma) were then applied with Hoechst nuclear dye. Images were acquired using a
fluorescence microscope (Olympus IX2) or a laser scanning confocal microscope (Leica
TCS SP5 II). Cell alignment was quantified from α-actinin images with ImageJ. Cross-
sectional areas were estimated from z-stack images obtained with 40X water-immersion
objective attached to the confocal microscope. Fine details of sarcomeric structure and actin
remodeling within the myotubes were visualized using confocal images taken with 63X
water-immersion objective.
Conclusion
In this work, we generated micrometer-scale, optically excitable 3D skeletal muscle
bioactuators from genetically engineered mouse myoblasts expressing ChR2. We
demonstrated multi-DOF motion by selectively activating individual myotubes within the
microtissues using confined illumination. Our study explores the utility of optogenetics for
skeletal muscle tissue engineering applications and for building a new class of muscle-
powered soft robots performing biomimetic tasks. The optogenetic approach offers high
spatiotemporal resolution for precise control of excitation. The presence of longitudinally
aligned, cross-striated myotubes and the level of measured specific dynamic tension show
that generated transgenic microtissues exhibit essential structural and functional properties
of engineered skeletal muscle.
Force generation and contraction characteristics are two very important performance metrics
of an engineered muscle actuator. To optimize the performance, the effects of several
soluble and mechanical stimuli have to be tested experimentally in a well-controlled
environment. Our system provides a non-invasive, reproducible and sensitive method to
measure the forces and mechanical stresses skeletal muscle cells exert during tissue
formation and twitch contractions over extended time periods using flexible cantilevers. In
addition to reporting tension, these cantilevers function as artificial tendons that anchor the
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microtissues. We can vary their elastic properties as well as the stiffness of the extracellular
matrix simultaneously with quantitative precision. Furthermore, the dimensions of generated
microtissues are small enough to allow rapid diffusion of soluble effectors and high-
throughput analysis of cytoskeletal structure. Thus, using this technology, we can prepare
hundreds of microtissues (130 SMTs per device) that are well-suited for examining how
various different biomechanical stimuli influence the structure and function of engineered
skeletal muscle bioactuators in a combinatorial manner. How to incorporate these powering
units into practical robotic devices is a next technical challenge, and we are currently
working on it.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Generation and light-induced stimulation of ChR2-expressing skeletal muscle cells in vitro.
(A) Fluorescence image of the membrane-bound ChR2-GFP signal (green) overlaid with F-
actin immunostaining (red) in C2C12 myoblasts. Nuclei are shown in blue. (B) Multi-
nucleated myotubes expressing the GFP signal (green). (C) Typical contraction pattern of a
ChR2-GFP expressing myotube upon stimulation with blue light pulses (10 mW mm−2) for
durations indicated by blue bars. A representative example of 20 experiments is shown. (D)
Representative repetitive contraction pattern evoked by local and full exposure of a ChR2-
GFP–expressing myotube with blue light pulses (10 mW mm−2) for durations indicated by
blue bars. (E) Selective activation of myotubes with local stimulation. Myotubes are denoted
by M1, M2 and M3 and regions of exposure are labeled with R1, R2, and R3. (F) Blue light
pulses confined to a region stimulate only the myotubes residing inside that specific region.
(Scale bars: A, 10 μm; B and E, 20 μm).
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Figure 2.
Generation of skeletal muscle microtissues (SMTs) tethered to elastic force sensors. (A)
Representative images depicting the time course of a contracting SMT. (B) Cross section
view of the CAD modeling of a single SMT. (C) Representative immunofluorescence
overlay of membrane-bound GFP signal (green) and nuclei staining (red) within
microtissues showing uniform cell distribution. (D) Representative F-actin imaging (red)
revealing the alignment of skeletal muscle myoblasts in the direction of mechanical stress
gradients within the microtissues after 3 days of culture. (E) Remodeling of actin (red)
within multi-nucleated myotubes. Nuclei are shown in green. (F) Effect of PDMS cantilever
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stiffness and device geometry on the skeletal muscle microtissue dimensions. (Scale bars:
100 μm).
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Figure 3.
Distribution and differentiation of skeletal muscle myotubes in engineered microtissues. (A–
C) Representative α-actinin immunostaining images showing the distribution and alignment
of striated myotubes after 3 weeks of culture. (D) Representative α-actinin immunostaining
image shows sarcomere formation and (E) a representative confocal section from the same
construct shows that aligned multinucleated myotubes exhibit ubiquitous cross-striations.
(F) 3D reconstruction of confocal slices for the construct shown in (D). The upper panel
shows the top and the lower panel shows the side view of the same microtissue. Nuclei
(green) are elongated in the direction of stress gradients. (G) Characterization of cell
alignment and myotube length in the microtissues. The location of each point in the scatter
plot shows the length and orientation of a myotube. Data are collected from 20 SMTs having
a total of 150 myotubes. (Scale bars: A and D, 50 μm; E, 25 μm).
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Figure 4.
Functional properties of SMTs and multi degrees of freedom actuation with local
stimulation (A) Representative recording of the static and dynamic tension of an SMT on
day 15. The microtissue is stimulated with a brief blue light pulse series (indicated by blue
bars). (B) Average static and dynamic tension for SMTs at day 15. Data are the average of
50 SMTs ± SEM. (C–E) Multi DOF actuation. Caps are outlined with black rectangles to
emphasize motion. Heat maps depicting degree of displacement.
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